Company: WHWK
Filing Date: 2025-01-31
Form Type: DEFM14A
Source: 0001193125-25-018470
Chunk: 141

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-31
Form: DEFM14A
Chunk 141
---
 Law and Venue The Divestiture Agreement is governed by and construed in accordance with the laws of the State of Delaware. The venue for disputes relating to the Divestiture Agreement is the Delaware Court of Chancery or, to the extent that the Delaware Court of Chancery does not have jurisdiction, federal or state court in the State of Delaware. - 94 -

Waiver of Jury Trial

Each of the parties to the Divestiture Agreement has irrevocably waived any and all right to trial by jury in any action arising out of or relating to the
Divestiture Agreement or the Divestiture.

- 95 -

AGREEMENTS RELATED TO THE DIVESTITURE Voting and Support Agreements In connection with entering into the Divestiture Agreement, on December 19, 2024, following the approval thereof by Aadi’s board of directors, Kaken and Aadi entered into the Support Agreements with each of the directors and executive officers of Aadi, certain of their affiliates, and one other significant stockholder of Aadi, who collectively beneficially own or control an aggregate of approximately 39.1% of the outstanding shares of Aadi’s common stock (the “Support Agreements”) as of the Record Date. Under the Support Agreements, the Support Agreement Stockholders have agreed to vote all of their shares of our common stock:

| • |     | in favor of (1) the Divestiture Proposal and the other transactions contemplated by the Divestiture                                                                                                                                                  
 Agreement (to the extent proposed to be voted upon or consented to by the Aadi stockholders) and the approval of the Divestiture Agreement that does not change the form of the consideration payable to Aadi upon the closing under the Divestiture 
 Agreement or reduce the consideration thereunder, (2) certain specified transactions as listed on a schedule to the Divestiture Agreement and (3) the Adjournment Proposal; and                                                                      |

| • |     | against (1) any action or agreement in favor of an acquisition proposal (including a Superior Proposal),                                                                                                                                          
 without regard to the terms of such acquisition proposal, or any of the transactions contemplated thereby, (2) any action or proposal that would reasonably be expected to result in a breach of any covenant, representation or warranty, or any 
 other obligation or agreement of Aadi or Aadi Sub under the Divestiture Agreement or of a Support Agreement Stockholder under the Support Agreement and (3) any action, proposal, transaction or agreement that would